Your browser doesn't support javascript.
Balancing Change and Certainty in Manufacturing
Pharmaceutical Technology Europe ; 35(4):10-13, 2023.
Article in English | ProQuest Central | ID: covidwho-20243772
ABSTRACT
According to research, for example, the bio/pharmaceutical manufacturing market should witness compound annual growth in the region of 11% between 2022 and 2027 (2), thanks in part to advancing manufacturing technologies. "Most recently, biopharmaceutical manufacturing has been impacted by pressures on supply chain," specifies Antonio Crincoli, vice president of Engineering, Pharma and Consumer Health, Catalent. [...]there is a focus on quality management systems that ensure data integrity and governance, and that digitization occurs with appropriate validation, also, where necessary, that there is segregation of operating systems to eliminate risk of corruption." Antonio Crincoli, Catalent "PAT and an emphasis on process understanding have been embraced by the majority of pharmaceutical manufacturers, and there are several case studies where both artificial intelligence (Al) and machine learning (ML) have led to improved quality or increased yield, even in good manufacturing practice (GMP) facilities," adds Byrd.
Keywords
Search on Google
Collection: Databases of international organizations Database: ProQuest Central Type of study: Prognostic study Language: English Journal: Pharmaceutical Technology Europe Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: ProQuest Central Type of study: Prognostic study Language: English Journal: Pharmaceutical Technology Europe Year: 2023 Document Type: Article